Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose–effect relationship of intrathecal bupivacaine based on spinal length in cesarean section
ChiCTR2200056643Phase 4Recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in procedural pain (5 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: Spinal length. Started Feb 2022; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2200056643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056643.